A Prospective, Multicenter, Long-Term Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects with Moderate-to-Severe Atopic Dermatitis
Clinical Trial Grant
Administered By
Dermatology
Awarded By
Galderma
Start Date
June 18, 2020
End Date
February 10, 2022
Administered By
Dermatology
Awarded By
Galderma
Start Date
June 18, 2020
End Date
February 10, 2022